We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Innovative, Easy-to-Use Molecular Diagnostics Platform Advances Newborn Screening

By LabMedica International staff writers
Posted on 28 Nov 2023
Print article
Image: The EONIS Q System enables faster, simplified newborn screening for SMA and SCID (Photo courtesy of Revvity)
Image: The EONIS Q System enables faster, simplified newborn screening for SMA and SCID (Photo courtesy of Revvity)

Newborn screening is essential for identifying and addressing potential health issues in infants early on, improving their long-term health prospects. Screening centers are continuously working to enhance their efficiency and adapt their spaces to meet modern laboratory standards. The global push to include screenings for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) in newborns is increasing. Early detection of these inherited conditions is crucial for effective treatment. For SMA, there are therapies available to halt the disease's progression. In cases of SCID, treatments combining immunoglobulin and stem cell therapies can be potentially curative if administered promptly. However, molecular testing for these and other congenital disorders has been limited, often due to costs and the specialized skills needed for conducting and interpreting these tests.

Revvity Inc. (Waltham, MA, USA) has launched the EONIS Q system which has received CE-IVD certification, allowing laboratories in countries recognizing CE marking to implement molecular testing for SMA and SCID in newborns. The EONIS Q system offers a simplified and efficient process for molecular testing of SMA and SCID. It includes the EONIS Q96 instrument, the EONIS SCID-SMA kit, and the EONIS EASI software, designed for an easy workflow. The system delivers results in about three hours from sample receipt. It stands out for its software capabilities and requires no washing steps, and fewer pipetting and centrifuging actions, reducing manual labor. It also uses fewer consumables and disposable plastics, making it a resource and cost-effective option for laboratories. The system's compact design and smaller size make it suitable for various lab environments, particularly beneficial for small to medium-sized labs, even those without a dedicated PCR clean room.

“Helping children get a healthier start to life is at the heart of our work and making molecular testing for inherited conditions like SMA and SCID more accessible can help further that aim,” said Petra Furu, general manager of reproductive health at Revvity. “Without compromising quality, speed or test result accuracy, the EONIS Q system is designed to break down some of the common barriers that prevent newborn screening labs from adopting these tests.”

Related Links:
Revvity Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.